Initially awarded $50 million, he now must choose between a reduced award of $1.6 million, or a new trial.
Related posts:
- Malpractice plaintiff wins case, wants more
- The choice between malpractice and insurance fraud
- Merck’s prevailing Vioxx strategy
- Lawyers win again, patients lose
- Faces of meth
- The many faces of appendicitis
- The baby with two faces
KevinMD.com on Facebook
{ 2 comments }
Well, it’s not entirely his choice. That’s just whether he wants to accept the judge’s ruling. Merck doesn’t have to accept it either way and can always appeal.
We’re still a ways from any money changing hands. Which kind of illustrates the folly of forming opinions based on large verdicts alone. There’s a LOT that has to happen before the case is over.
There is the occasional article that gives me faith in the wisdom of our courts. Occasionally,…
b
Comments on this entry are closed.